Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting stiffness-dependent YAP/TAZ restores angiogenesis dynamics impaired by ALK1 knockout in silico. | PLoS Comput Biol | 2026 | 42461962 | PubTator, text mining | PubMed |
| Gene-Specific Endothelial Programs Drive AVM Pathogenesis in SMAD4 and ALK1 Loss-of-Function. | Arterioscler Thromb Vasc Biol | 2026 | 42460472 | PubTator, text mining | PubMed |
| Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report. | Front Oncol | 2026 | 42388640 | PubTator, text mining | PubMed |
| Lung Pericytes: Molecular Mechanisms, Signaling Pathways, and Roles in Pulmonary Diseases. | Compr Physiol | 2026 | 42381220 | PubTator, text mining | PubMed |
| Nitazoxanide activates BMP9-ALK1-SMAD signaling cascade and improves HHT vascular pathology. | bioRxiv | 2026 | 42182190 | PubTator, text mining | PubMed |
| Cutaneous Hemangioma With Epithelioid Features Harboring a TPM4::ALK Fusion. | J Cutan Pathol | 2026 | 42173697 | PubTator, text mining | PubMed |
| Localized episcleral ALK-positive histiocytosis: a novel adult presentation confirmed by ALK gene rearrangement. | Orbit | 2026 | 42155969 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Core Genes, Key Pathways, and Immune Infiltration in Intervertebral Disc Degeneration Using Machine Learning and Experimental Validation. | Iran J Allergy Asthma Immunol | 2026 | 42130144 | PubTator, text mining | PubMed |
| Decoding brain arteriovenous malformations: from genetic insights to modeling the vascular maze. | Acta Neuropathol Commun | 2026 | 42106885 | PubTator, text mining | PubMed |
| Designed Minibinders Rewire Receptor Signaling to Enable Functional Human Myogenic Reprogramming. | bioRxiv | 2026 | 42094432 | PubTator, text mining | PubMed |
| Clinical characteristics and surgical management of adult gastric inflammatory myofibroblastic tumors: A systematic review and pooled individual patient data analysis. | Eur J Surg Oncol | 2026 | 42034576 | PubTator, text mining | PubMed |
| Secretory leukocyte peptidase inhibitor as a dynamic radiotherapy response biomarker in esophageal squamous cell carcinoma. | MedScience | 2026 | 42008079 | PubTator, text mining | PubMed |
| Bioactive secretory leukocyte protease inhibitor (SLPI)-derived short peptides (SDSPs) attenuate LPS-induced inflammatory responses in macrophages. | Sci Rep | 2026 | 41991980 | PubTator, text mining | PubMed |
| A novel strategy for secretory leukocyte protease inhibitor (SLPI) immobilization on alkaline-etched titanium via a plasma-polymerized interlayer and covalent coupling to enhance osteoblast activity. | Sci Rep | 2026 | 41957418 | PubTator, text mining | PubMed |
| A secretory leukocyte protease inhibitor-derived small peptide coating on a titanium surface enhances osteoblast adhesion, proliferation, and reduces bacterial adhesion. | Sci Rep | 2026 | 41942721 | PubTator, text mining | PubMed |
| Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multi-omic analyses of a syndrome variably associated with systemic sclerosis. | Acta Neuropathol | 2026 | 41934478 | PubTator, text mining | PubMed |
| SLPI/FBW7/c-Myc Axis Reduces Gemcitabine Sensitivity in PDAC by Enhancing Glycolysis and Impairing NK Cell Immunity. | Cancer Sci | 2026 | 41923319 | PubTator, text mining | PubMed |
| Inflammatory Myofibroblastic Tumor of the Lung: A Rare Find in an Elderly Female. | J Investig Med High Impact Case Rep | 2026 | 41914218 | PubTator, text mining | PubMed |
| In-Depth Multi-Assembler Venom-Gland Transcriptomics of Three Medically Important Colombian Snakes Highlights Diversity of Accessory, Low-Abundance Protein Families. | Toxins (Basel) | 2026 | 41893541 | PubTator, text mining | PubMed |
| Salivary immune alteration persists after caries treatment. | Sci Rep | 2026 | 41844736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=2